MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative...
11 insider purchases on record · latest filing 2024-08-14.
Insiders have also filed 85 sale transactions at MGTX.